WIRB-Copernicus Group

Is eConsent adoption poised to grow?

Friday, September 1, 2017

Activity in the eConsent sector has risen considerably during the past six months, with Medidata’s acquisition of electronic informed consent pioneer Mytrus and the entry of new market players, even though widespread industry adoption of the technology has appeared to have stalled.

[Read More]

High costs and recruitment issues drive the globalization of clinical trials

Monday, August 21, 2017

The pursuit of global trials is increasing. A report by SCORR Marketing and Applied Clinical Trials examined the reasons why companies are pursuing global clinical trials and the challenges they face in conducting them. The top two reasons cited in the survey for trials exiting the U.S. and Western Europe and moving to other regions were high costs and  patient recruitment difficulty.

[Read More]

WCG’s MedAvante-ProPhase expands executives

Tuesday, August 15, 2017

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, announced that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvanteProPhase, the Group’s electronic clinical outcomes assessment (eCOA) arm. Herne and Cioffi are tasked with expanding MedAvante-ProPhase’s already formidable portfolio of services and technologies, which improve the quality of clinical trial data collection and analysis in the fields of CNS and mental health.

[Read More]

WCG recognized for clinical trial awareness and education support

Wednesday, June 28, 2017

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent, nonprofit organization dedicated to educating patients and the public about clinical research, is pleased to thank and recognize WIRB-Copernicus Group (WCG) for its recent support of CISCRP’s Medical Heroes 5K Run & Walk, held last week in Chicago, and its additional donation to CISCRP’s clinical research education and outreach programs.

[Read More]